Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 4 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Recs

0
Player Avatar cashman79 (37.50) Submitted: 9/15/2010 9:43:47 AM : Outperform Start Price: $13.88 ALKS Score: -3.14

watch

Featured Broker Partners


Advertisement